Intestinal drug absorption and metabolism. II. Kinetic aspects of intestinal glucuronide conjugation.

作者信息

Barr W H, Riegelman S

出版信息

J Pharm Sci. 1970 Feb;59(2):164-8. doi: 10.1002/jps.2600590205.

DOI:10.1002/jps.2600590205

PMID:5413732

Abstract

摘要

相似文献

Intestinal drug absorption and metabolism. II. Kinetic aspects of intestinal glucuronide conjugation.

J Pharm Sci. 1970 Feb;59(2):164-8. doi: 10.1002/jps.2600590205.

Intestinal drug absorption and metabolism. I. Comparison of methods and models to study physiological factors of in vitro and in vivo intestinal absorption.

J Pharm Sci. 1970 Feb;59(2):154-63. doi: 10.1002/jps.2600590204.

Conjugation of salicylamide in the intestinal wall of dogs and rabbits.

J Pharmacobiodyn. 1986 Nov;9(11):917-22. doi: 10.1248/bpb1978.9.917.

Effect of complex formation on drug absorption. IX. Determination of the intestinal transfer rate constant of the salicylamide-caffeine complex.

J Pharm Sci. 1969 Jan;58(1):79-83. doi: 10.1002/jps.2600580116.

Apparent directional permeability coefficients for drug ions: in vitro intestinal perfusion studies.

J Pharm Sci. 1970 May;59(5):590-5. doi: 10.1002/jps.2600590503.

Intestinal first-pass metabolism of phenacetin, acetaminophen, ethenzamide and salicylamide in rabbits pretreated with 3,4-benzo[a]pyrene.

Biochem Pharmacol. 1987 Apr 1;36(7):1171-4. doi: 10.1016/0006-2952(87)90430-8.

Naphthol metabolism: glucuronide conjugation and transport by the rat intestine in vitro.

Toxicol Appl Pharmacol. 1974 Sep;29(3):404-19. doi: 10.1016/0041-008x(74)90113-6.

Drug biotransformation interactions in man. I. Mutual inhibition in glucuronide formation of salicylic acid and salicylamide in man.

J Pharm Sci. 1968 Aug;57(8):1330-5. doi: 10.1002/jps.2600570811.

Intestinal azo reduction and glucuronide conjugation of prontosil.

Biochem J. 1971 Nov;125(2):24P. doi: 10.1042/bj1250024pa.

An assessment of salicylic acid-induced mucosal damage in vivo by measuring the metabolism of salicylamide in rabbit intestine.

Chem Pharm Bull (Tokyo). 1992 Mar;40(3):815-8. doi: 10.1248/cpb.40.815.

引用本文的文献

The mucosa of the small intestine: how clinically relevant as an organ of drug metabolism?

Clin Pharmacokinet. 2002;41(4):235-53. doi: 10.2165/00003088-200241040-00001.

Rate-limiting barriers to intestinal drug absorption: a review.

J Pharmacokinet Biopharm. 1980 Aug;8(4):321-34. doi: 10.1007/BF01059381.

Drug metabolism by the gastrointestinal mucosa.

Clin Pharmacokinet. 1981 Jul-Aug;6(4):259-74. doi: 10.2165/00003088-198106040-00002.

Effect of route of administration on drug disposition.

J Pharmacokinet Biopharm. 1973 Oct;1(5):419-34. doi: 10.1007/BF01059666.

A modern view of pharmacokinetics.

J Pharmacokinet Biopharm. 1973 Oct;1(5):363-401. doi: 10.1007/BF01059664.

Salycylamide glucuronide formation in liver disease and its change by drugs.

Gastroenterol Jpn. 1975;10(2):120-31. doi: 10.1007/BF02774839.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验